Indicative Announcement on Expected Loss in Performance for 2025

About this update from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

Indicative Announcement on Expected Loss in Performance for 2025 The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Zhejiang East Asia Pharmaceutical Co., Ltd. Class A